Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395315 · ClinicalTrials.gov registry record
Alveolar Bone Changes in Diabetes (ABCD) Study
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 42
- Enrollment target
NCT02395315 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 42 participants.
The verdict
NCT02395315 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
Study Summary
Type 2 Diabetes Mellitus (DM) is a very prevalent metabolic disorder in the adult population affecting roughly 17.7 million people in the US alone. The harmful effect of DM on implant integration and survival has been attributed to vascular complications in the alveolar bone that lead to compromised blood supply and decreased bone density. Nonetheless, the specific detrimental effects of DM in the alveolar bone have not been investigated in humans. People with DM generally lose more teeth than persons without diabetes, but implant placement in not well controlled diabetics is not routinely performed due to the lack of relevant evidence and the risk for implant failure and associated complications. Chemically modified, micro-rough, hydrophilic (SLActive®) titanium implant surfaces have been shown to accelerate osseointegration of dental implants placed in diabetic animals. It has been hypothesized that this enhanced biologic response is due to the biocompatibility and hydrophilicity of the surface that actively attracts blood and is populated by progenitor cells, and growth factors that improve stromal cell differentiation. Hypotheses: It is hypothesized that hyperglycemia results in compromised vascularity in the mandible. Thus, hydrophilic TiZr implant surfaces (Roxolid®) that actively attract fluids and possess excellent osteoconductive properties, may enhance peri-implant bone response in diabetic patients to levels comparable to well-controlled diabetics.
Interventions
- DEVICE Well-controlled diabetic (WC)
- DEVICE Poorly controlled diabetics (PC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2015-12 |
| Est. Completion | 2021-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02395315
The ClinicalTrials.gov registry entry for NCT02395315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Well-controlled diabetic (WC) is the first listed.
NCT02395315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02395315 about?
NCT02395315 is a clinical study titled "Alveolar Bone Changes in Diabetes (ABCD) Study". Type 2 Diabetes Mellitus (DM) is a very prevalent metabolic disorder in the adult population affecting roughly 17.7 million people in the US alone. The harmful effect of DM on implant integration and survival has been attributed to vascular complications in the alveolar bone that lead to compromised...
What is the current status of trial NCT02395315?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2015-12. Estimated completion is 2021-11-07.
What interventions are being tested in trial NCT02395315?
The interventions under investigation include: Well-controlled diabetic (WC) (DEVICE), Poorly controlled diabetics (PC) (DEVICE).
Who is sponsoring clinical trial NCT02395315?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.